|Feb||19||View ORI's Funding Opportunity Announcements on the NIH Guide||
ORI is seeking to fund projects that foster innovative approaches to empirical research on societal, organizational, group, and individual factors that affect, both positively and negatively, integrity in research. The research will be reviewed and funded in a two-phase process. For this first phase, ORI is seeking small-scale, developmental research projects. ORI anticipates that Phase I awards will have a ceiling of up to $75,000 for a period of 12 months
|Feb||12||Funding Opportunity: Conference Grants on Research Integrity||
The Office of Research Integrity (ORI) seeks to support conferences to develop multi-disciplinary networks to build upon existing evidence-based research and stimulate innovative approaches to preventing research misconduct and promoting research integrity. ORI is especially interested in supporting conferences that lead to extramural grant applications on research on research integrity and peer-reviewed publications.
|Jan||22||New Research Misconduct Finding: Dong Xiao||
Dong Xiao, Ph.D. admitted that he had “intentionally fabricated data contained in a paper entitled ‘Guggulsterone inhibits prostate cancer growth via inactivation of Akt regulated by ATP citrate signaling."
|Jan||20||New Research Misconduct Finding: Bin Kang||
ORI found that Dr. Bin Kang engaged in research misconduct by falsifying data that were included in the following two publications and two grant applications.
|Dec||19||New Research Misconduct Finding: Rosie H. Xing||
ORI found that Dr. H. Rosie Xing engaged in research misconduct by falsifying images in research supported by National Cancer Institute (NCI), National Institutes of Health (NIH).